| 摘要 |
Reagents which regulate human matriptase-like serine protease activity and reagents which bind to human matriptase-like serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating cancer, including metastasis of malignant cells, chronic obstructive pulmonary disease, disorders of the peripheral or central nervous system, and cardiovascular disorders. |
